AbCellera Biologics (ABCL) Bɛn Dɛŋɛn Akɔc
Bɛ̈ny cɔk aya$12.72Aciic 25 Sep 2026 19:59 UTC
Change+0.47%
AI forecast: ABCL
AI ekek aŋok wɛlɛɛl bɛn bɛn lɔŋɔŋ, bɛn bɛn cɔlɔŋ, kɛ bɛn bɛn cɔlɔŋ. Cɔkɔkɔkɔ cɔlɔŋ bɛn bɛn lɔŋɔŋ. Aŋok wɛlɛɛl aŋok wɛlɛɛl, aŋok wɛlɛɛl aŋok wɛlɛɛl.
Bɛn cɔk ɛcɔk 6
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nyɛn cɔk aya bɛn
Ditëëk ë bɛ̈ɛ̈r ë cë lɔ – ditëëk ë cë lɔ kee aköl aköl ë bɛ̈ɛ̈r ë cë lɔ – aye Premium.
Unlock PremiumBɛn kɔc ke bɛn
AbCellera Biologics Inc. operates as a pharmaceutical company. The company researches and develops next-generation therapeutic antibodies using a combination of technologies, including patented immunizations, microfluidics, high-throughput imaging, genomics, computing, and laboratory automation. AbCellera Biologics serves customers in Canada.
